eBook | Life Sciences | CX

AI-driven insight discovery for life sciences with deCypher

deCypher helps pharmaceutical and life sciences organizations turn complex, cross-silo data into accurate, conversational insight.

Download as PDF 13th July, 2026
element
element

Your next breakthrough could be buried in data you can’t easily interrogate. Our solution, deCypher helps turns plain-language questions into accurate, relevant insights across complex data landscapes.

Search, extract, and analyze data. Simply by asking

  • Pharmaceutical data is highly interconnected yet trapped in silos, and traditional databases were not built to extract the relationships that matter most.
  • Natural language querying is emerging as the default access layer, replacing syntax with intent across genomic, clinical, and literature sources.
  • Four connected capabilities define production-grade querying in life sciences: semantic understanding, integration, optimization, and adaptive learning.
  • deCypher brings these capabilities together in a single cloud-native system, engineered for the volume, complexity, and privacy demands of life sciences.
  • The impact lands where it matters most: drug discovery, clinical trials, and patient outcomes.

Why life sciences data is the hardest to interrogate in any industry

Life sciences is being reshaped by a new set of research and operational requirements. Organizations need:

  • Faster access to insight across drug discovery, clinical trials, and patient outcomes
  • Cross-silo analysis across genomic, clinical, and literature data
  • Interfaces that any user can navigate, regardless of technical expertise
  • Strict data privacy and compliance across every point of interaction

At the same time, they must modernize how data is queried, integrated, and shared, while keeping security, governance, and scientific rigor intact. AI is driving transformation across the industry, reshaping how researchers, clinicians, and data analysts interact with pharmaceutical data. As demand grows for real-time insight, cross-source analysis, and personalized therapies, organizations need query models that are more intuitive, integrated, and easier to scale. deCypher helps life sciences organizations address this shift through an end-to-end natural language querying capability, powered by GPT-based semantic understanding, cross-source integration, and adaptive learning.

deCypher: A GPT-based querying solution built for the demands of life sciences

deCypher is the natural language querying solution at the core of life sciences insight discovery. It brings the four capabilities together in a single cloud-native, agent-oriented system, engineered for the volume, complexity, and privacy demands of pharmaceutical data.

What it is: A GPT-based conversational querying solution that closes the gap between the question and the answer, so users can search, extract, and analyze data by simply asking.

Who it is for: Researchers, clinicians, and data analysts across drug discovery, clinical trials, and patient outcomes, at every level of technical expertise.

What it changes:

  • Complex queries become a conversation, so people closest to the science can interrogate their own data directly.
  • A single interface reaches across genomic data, clinical records, and literature, revealing relationships that live across silos.
  • Query optimization and adaptive learning shorten the path from question to answer and sharpen relevance over time.
  • Strict data privacy standards are built into every interaction, supporting collaboration without compromising compliance

Bolting a chatbot onto an existing database is not the same as understanding the question. deCypher is built to close that gap end-to-end, so answers are grounded in real semantic understanding and integrated retrieval, not confident approximation.

How deCypher turns fragmented data estates into a single conversational surface

Semantic querying

Interprets the meaning behind a question, with the context awareness required for specialized medical terminology and complex life sciences queries

Data integration

Unifies genomic data, clinical records, and literature behind a single conversational interface, with support for the multiple data structures common to life sciences databases

Query optimization

Refines queries in flight and surface improvements based on how similar queries have been resolved before

Adaptive learning

Improves the system's understanding of queries continuously and the relevance of results as it is used

Inside the architecture that makes conversational querying enterprise-ready

Behind the conversational surface sits a cloud-native architecture designed for the complexity of pharmaceutical data.

  • Agent orchestration: Requests are handled by a set of purpose-built agents—a helper agent, a general info agent, a code interpreter agent, and an intelli-data agent, each tuned for a specific class of task.
  • Orchestration frameworks: LangChain and Python coordinate the agents, route requests, and manage state, drawing on foundation models such as those from OpenAI for the underlying semantic capability.
  • Storage and retrieval: Azure Cosmos, PostgreSQL, and Azure AI Search work together to support structured, semi-structured, and unstructured life sciences data, with fast, relevance-tuned retrieval across the full corpus.
  • User experience: A responsive React and Next.js front end keeps interactions fast and intuitive, while the heavy lifting happens out of sight.
  • Governance and privacy: Access controls, audit trails, and data residency requirements are built into the retrieval and orchestration layers rather than added afterwards.

The architecture is what allows the four capabilities to work together as a single system, rather than as loosely connected tools.

What changes when data becomes directly answerable?

  • Access moves closer to the science: Answers that once required specialized skills or a technical intermediary become directly available to the researcher, clinician, or analyst who has the question.
  • Value compounds through use: Because the system keeps learning from how it is used, its understanding of queries and the relevance of its results improve with every interaction, so the return grows rather than plateaus.
  • Collaboration becomes the default: When researchers, clinicians, and data analysts all work from the same accessible source of insight, sequential handoffs give way to shared inquiry.
  • The payoff lands where it matters most: In drug discovery, clinical trials, and patient outcomes, data that was once difficult to reach becomes the foundation for confident, well-informed decisions.

deCypher FAQs: Querying life sciences data in plain language

deCypher helps researchers, clinicians, and data analysts query complex, siloed pharmaceutical data in plain language, so they can search, extract, and analyze information without a technical intermediary.

deCypher combines semantic understanding, cross-source integration, query optimization, and adaptive learning in a single system, rather than layering a conversational interface over an unchanged database.

deCypher spans structured genomic data, semi-structured clinical records, and unstructured literature, unifying them behind a single conversational interface for cross-source analysis.

The impact lands most directly in drug discovery, clinical trials, and patient outcomes, where cross-silo pattern recognition and semantic understanding shape the quality of scientific decisions.

deCypher adheres to strict data privacy standards, with access controls, audit trails, and data residency requirements built into the retrieval and orchestration layers rather than added afterwards.

Forward-looking thoughts and compelling stories

Sentient-Commercial-Ecosystem-Transforming-Life-Sciences-Banner

White Paper

  • Life Sciences

Sentient Commercial Ecosystems: Transforming Life Sciences

Sentient Commercial Ecosystems: Transforming Life Sciences Read more  
POV-Beyond-the-Use-Case-Trap-rethinking-AI-ROI-in-Healthcare-Life-Sciences

Point of View

  • Healthcare
  • Life Sciences

Rethinking AI’s ROI in HLS beyond the ‘use case trap’

Rethinking AI’s ROI in HLS beyond the ‘use case trap’ Read more  
Novo-Data-Modernization-Case-Study-Design

Case Study

  • Life Sciences

Global pharma cuts decision cycles by 66% with AI

Global pharma cuts decision cycles by 66% with AI Read more  

Point of View

  • Healthcare

Why agentic AI is pharmacy’s strategic imperative for growth

Why agentic AI is pharmacy’s strategic imperative for growth Read more  

You define the north star, We pave the digital path

Let's connect   
elements
elements